中泰国际每日晨讯-20260330

Market Overview - On March 27, uncertainty in US-Iran ceasefire negotiations led to market volatility, with the Hang Seng Index rising by 95 points (0.4%) to close at 24,951 points, failing to break the 25,000 mark[1] - The Hang Seng Tech Index increased by 16 points (0.4%) to 4,778 points, with total market turnover decreasing to HKD 263.1 billion from HKD 261.7 billion the previous day[1] - Net outflow of southbound funds amounted to HKD 2.88 billion[1] Sector Performance - The pharmaceutical sector showed strength, with notable gains: CSPC Pharmaceutical (1093 HK) up 13.8%, WuXi Biologics (2269 HK) up 2.6%, Innovent Biologics (1801 HK) up 7.7%, and Hansoh Pharmaceutical (1276 HK) up 7.8%[1] - The restaurant sector rebounded after previous declines, with Haidilao (6862 HK) rising by 1.0% to 4.9%[1] US Market Dynamics - The US stock market faced continued uncertainty due to the Middle East conflict, with the Dow Jones Industrial Average falling by 793 points (1.7%) to 45,166 points, and the Nasdaq Composite down by 459 points (2.1%) to 20,948 points[2] - The 10-year US Treasury yield reached 4.46%, the highest in 8 months, while the 20-year yield surpassed 5%[2] Macroeconomic Data - In the first two months of the year, China's industrial enterprises above designated size reported total profits of CNY 1.02 trillion, a year-on-year increase of 15.2%, accelerating by 14.6 percentage points compared to the previous year[3] Automotive Sector Insights - Chinese automakers regained growth in the European market, with hybrid vehicle registrations increasing to 16%, up 1 percentage point, and pure electric vehicle market share rising by 2 percentage points to 14%[4] - BYD (1211 HK) rose by 3.7% and Leap Motor (9863 HK) by 5.3% amid rising oil prices[4] Renewable Energy and Utilities - The renewable energy and utilities sector showed mixed performance, with notable gains in high-performing stocks: Flat Glass Group (6865 HK) up 6.8%, Wasion Group (3393 HK) up 7.5%, and CGN Mining (1164 HK) up 3.1%[4] Pharmaceutical Sector Developments - The Hang Seng Healthcare Index surged by 4.9%, outperforming the Hang Seng Index, with significant increases in innovative drug companies[5] - CSPC Pharmaceutical's stock rose by 13.9%, potentially linked to a USD 1.2 billion upfront payment from AstraZeneca (AZN US) expected to be recognized this year[5]